Compliance in the Physicians' Health Study
NCT00005404 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-03-16
Summary
To evaluate the relationships of compliance in taking aspirin or aspirin placebo with the risk of major cardiovascular endpoints, using data collected in the Physicians' Health Study.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Coronary Disease
- Myocardial Infarction
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1991-02-28
- Completion
- 1993-01-31
More Related Trials
-
Aspirin-Myocardial Infarction Study (AMIS)
NCT00000491 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease
NCT03757156 ·Status: UNKNOWN ·Phase: NA
-
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
NCT00272337 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)
NCT00981032 ·Status: COMPLETED ·Phase: NA
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease
NCT01820429 ·Status: COMPLETED
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Responsiveness in Women at Risk for Cardiac Events
NCT00818337 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms of Action of Acetaminophen
NCT00646906 ·Status: COMPLETED ·Phase: NA
-
Asymptomatic Carotid Artery Plaque Study (ACAPS)
NCT00000469 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069 ·Status: RECRUITING ·Phase: PHASE4
-
Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study
NCT01534026 ·Status: COMPLETED ·Phase: PHASE4
-
Physiopathology of Rapid Aspirin Desensitization
NCT01118546 ·Status: COMPLETED
-
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
NCT04053894 ·Status: UNKNOWN
-
Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France
NCT01238809 ·Status: WITHDRAWN
-
Aspirin Effectiveness Study
NCT01113060 ·Status: UNKNOWN
-
Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects
NCT00898222 ·Status: COMPLETED ·Phase: NA
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension
NCT00384865 ·Status: TERMINATED ·Phase: PHASE2
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Serum LDL Lowering on Aspirin Resistance
NCT00466154 ·Status: COMPLETED ·Phase: NA
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 ·Status: COMPLETED